- Most often, patients seek treatment owing to the psychological stress that accompanies the cosmetic appearance of skin lesions. They should be warned about the adverse effects of therapeutic medication such as skin atrophy, the formation of striae, telangiectasis. The use of psoralen in PUVA may be associated with hepatotoxicity. Females in the adolescent age group should be warned about the adverse effects of medication on pregnancy.

- Many of the patients could get a relapse of skin lesions after successful initial treatment. Educating the patients about underlying causes helps reduce the relapse.

- Patients are advised to monitor and report to the physician if any systemic symptoms occur, along with the skin lesions.